Kalisvaart Kees J, de Jonghe Jos F M, Bogaards Marja J, Vreeswijk Ralph, Egberts Toine C G, Burger Bart J, Eikelenboom Piet, van Gool Willem A
Department of Geriatric Medicine, Medical Center Alkmaar, Alkmaar, The Netherlands.
J Am Geriatr Soc. 2005 Oct;53(10):1658-66. doi: 10.1111/j.1532-5415.2005.53503.x.
To study the effectiveness of haloperidol prophylaxis on incidence, severity, and duration of postoperative delirium in elderly hip-surgery patients at risk for delirium.
Randomized, double-blind, placebo-controlled trial.
Large medical school-affiliated general hospital in Alkmaar, The Netherlands.
A total of 430 hip-surgery patients aged 70 and older at risk for postoperative delirium.
Haloperidol 1.5 mg/d or placebo was started preoperatively and continued for up to 3 days postoperatively. Proactive geriatric consultation was provided for all randomized patients.
The primary outcome was the incidence of postoperative delirium (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, and Confusion Assessment Method criteria). Secondary outcomes were the severity of delirium (Delirium Rating Scale, revised version-98 (DRS-R-98)), the duration of delirium, and the length of hospital stay.
The overall incidence of postoperative delirium was 15.8%. The percentage of patients with postoperative delirium in the haloperidol and placebo treatment condition was 15.1% and 16.5%, respectively (relative risk=0.91, 95% confidence interval (CI)=0.6-1.3); the mean highest DRS-R-98 score+/-standard deviation was 14.4+/-3.4 and 18.4+/-4.3, respectively (mean difference 4.0, 95% CI=2.0-5.8; P<.001); delirium duration was 5.4 versus 11.8 days, respectively (mean difference 6.4 days, 95% CI=4.0-8.0; P<.001); and the mean number of days in the hospital was 17.1+/-11.1 and 22.6+/-16.7, respectively (mean difference 5.5 days, 95% CI=1.4-2.3; P<.001). No haloperidol-related side effects were noted.
Low-dose haloperidol prophylactic treatment demonstrated no efficacy in reducing the incidence of postoperative delirium. It did have a positive effect on the severity and duration of delirium. Moreover, haloperidol reduced the number of days patients stayed in the hospital, and the therapy was well tolerated.
研究氟哌啶醇预防对有谵妄风险的老年髋关节手术患者术后谵妄的发生率、严重程度及持续时间的有效性。
随机、双盲、安慰剂对照试验。
荷兰阿尔克马尔一家大型医学院附属医院。
共430名年龄在70岁及以上且有术后谵妄风险的髋关节手术患者。
术前开始使用1.5毫克/天的氟哌啶醇或安慰剂,并持续至术后3天。为所有随机分组的患者提供积极的老年病会诊。
主要结局是术后谵妄的发生率(依据《精神障碍诊断与统计手册》第四版及意识错乱评估方法标准)。次要结局包括谵妄的严重程度(谵妄评定量表修订版-98(DRS-R-98))、谵妄持续时间及住院时间。
术后谵妄的总体发生率为15.8%。氟哌啶醇治疗组和安慰剂治疗组术后发生谵妄的患者百分比分别为15.1%和16.5%(相对危险度=0.91,95%置信区间(CI)=0.6 - 1.3);DRS-R-98的平均最高得分±标准差分别为14.4±3.4和18.4±4.3(平均差值4.0,95% CI=2.0 - 5.8;P<0.001);谵妄持续时间分别为5.4天和11.8天(平均差值6.4天,95% CI=4.0 - 8.0;P<0.001);平均住院天数分别为17.1±11.1天和22.6±16.7天(平均差值5.5天,95% CI=1.4 - 2.3;P<0.001)。未观察到与氟哌啶醇相关的副作用。
低剂量氟哌啶醇预防性治疗在降低术后谵妄发生率方面未显示出疗效。但对谵妄的严重程度和持续时间有积极影响。此外,氟哌啶醇减少了患者的住院天数,且该治疗耐受性良好。